142 related articles for article (PubMed ID: 12599586)
1. [PSA follow-up after radical prostatectomy].
Egawa S; Baba S
Nihon Rinsho; 2002 Dec; 60 Suppl 11():284-8. PubMed ID: 12599586
[No Abstract] [Full Text] [Related]
2. [Serum and urinary PSA in the diagnosis of PSA failure after radical prostatectomy].
Arai Y; Okubo K
Nihon Rinsho; 2000 Jul; 58 Suppl():357-61. PubMed ID: 11022749
[No Abstract] [Full Text] [Related]
3. [The value of PSA follow-up in recurrent prostate carcinoma after radical prostatovesiculectomy].
Trinkler F; Hauri D
Helv Chir Acta; 1994 Dec; 60(6):1081-5. PubMed ID: 7533147
[TBL] [Abstract][Full Text] [Related]
4. Digital rectal examination is no longer necessary in the routine follow-up of men with undetectable prostate specific antigen after radical prostatectomy: the implications for follow-up.
Chaplin BJ; Wildhagen MF; Schroder FH; Kirkels WJ; Bangma CH
Eur Urol; 2005 Dec; 48(6):906-10. PubMed ID: 16126322
[TBL] [Abstract][Full Text] [Related]
5. Improved risk stratification for biochemical recurrence after radical prostatectomy using a novel risk group system based on prostate specific antigen density and biopsy Gleason score.
Freedland SJ; Wieder JA; Jack GS; Dorey F; deKernion JB; Aronson WJ
J Urol; 2002 Jul; 168(1):110-5. PubMed ID: 12050502
[TBL] [Abstract][Full Text] [Related]
6. Digital rectal examination and imaging studies are unnecessary in men with undetectable prostate specific antigen following radical prostatectomy.
Pound CR; Christens-Barry OW; Gurganus RT; Partin AW; Walsh PC
J Urol; 1999 Oct; 162(4):1337-40. PubMed ID: 10492192
[TBL] [Abstract][Full Text] [Related]
7. Spurious prostate-specific antigen (PSA) recurrence after radical prostatectomy: interference by human antimouse heterophile antibodies.
Park S; Wians FH; Cadeddu JA
Int J Urol; 2007 Mar; 14(3):251-3. PubMed ID: 17430267
[TBL] [Abstract][Full Text] [Related]
8. [The role of prostate-specific antigen in the diagnosis and treatment of prostatic adenocarcinoma].
Stamey TA
Urologe A; 1990 Mar; 29(2):52-64. PubMed ID: 1691883
[TBL] [Abstract][Full Text] [Related]
9. Sensitive prostate specific antigen measurements identify men with long disease-free intervals and differentiate aggressive from indolent cancer recurrences within 2 years after radical prostatectomy.
Witherspoon LR; Lapeyrolerie T
J Urol; 1997 Apr; 157(4):1322-8. PubMed ID: 9120931
[TBL] [Abstract][Full Text] [Related]
10. Preoperative prediction of tumor heterogeneity and recurrence after radical prostatectomy for localized prostatic carcinoma with digital rectal, examination prostate specific antigen and the results of 6 systematic biopsies.
Huland H; Hammerer P; Henke RP; Huland E
J Urol; 1996 Apr; 155(4):1344-7. PubMed ID: 8632570
[TBL] [Abstract][Full Text] [Related]
11. Accuracy of predicting long-term prostate specific antigen outcome based on early prostate specific antigen recurrence results after radical prostatectomy.
Soergel TM; Koch MO; Foster RS; Bihrle R; Wahle G; Gardner T; Jung SH
J Urol; 2001 Dec; 166(6):2198-201. PubMed ID: 11696735
[TBL] [Abstract][Full Text] [Related]
12. Benign positive margins after radical prostatectomy means a poor prognosis--con.
Rubin MA; Montie JE
Urology; 2005 Feb; 65(2):221-3. PubMed ID: 15708026
[No Abstract] [Full Text] [Related]
13. The long-term clinical impact of biochemical recurrence of prostate cancer 5 or more years after radical prostatectomy.
Ward JF; Blute ML; Slezak J; Bergstralh EJ; Zincke H
J Urol; 2003 Nov; 170(5):1872-6. PubMed ID: 14532796
[TBL] [Abstract][Full Text] [Related]
14. Preoperative serum prostate specific antigen levels between 2 and 22 ng./ml. correlate poorly with post-radical prostatectomy cancer morphology: prostate specific antigen cure rates appear constant between 2 and 9 ng./ml.
Stamey TA; Johnstone IM; McNeal JE; Lu AY; Yemoto CM
J Urol; 2002 Jan; 167(1):103-11. PubMed ID: 11743285
[TBL] [Abstract][Full Text] [Related]
15. Is tumor vascularity in prostate core biopsies a predictor of PSA recurrence after radical prostatectomy?
Khatami A; Pihl CG; Norrby K; Hugosson J; Damber JE
Acta Oncol; 2005; 44(4):362-8. PubMed ID: 16120545
[TBL] [Abstract][Full Text] [Related]
16. Preoperative PSA level significantly associated with interval to biochemical progression after radical retropubic prostatectomy.
Gonzalez CM; Roehl KA; Antenor JV; Blunt LW; Han M; Catalona WJ
Urology; 2004 Oct; 64(4):723-8. PubMed ID: 15491709
[TBL] [Abstract][Full Text] [Related]
17. [Therapeutic strategy for prostate specific antigen (PSA) failure after radical prostatectomy].
Kinoshita H; Kamoto T; Mitsumori M; Kiyokawa T; Habuchi T; Kakehi Y; Hiraoka M; Ogawa O
Gan To Kagaku Ryoho; 2003 Jan; 30(1):32-7. PubMed ID: 12557702
[TBL] [Abstract][Full Text] [Related]
18. [The value of prostate-specific antigen in therapy follow-up of prostatic carcinoma].
Wirth MP; Pilarsky C
Urologe A; 1995 Jul; 34(4):297-302. PubMed ID: 7545844
[TBL] [Abstract][Full Text] [Related]
19. [PSA density, PSATZ, PSA velocity and PSA doubling time].
Tochigi T; Kawamura S; Kuwahara M
Nihon Rinsho; 2002 Dec; 60 Suppl 11():107-11. PubMed ID: 12599554
[No Abstract] [Full Text] [Related]
20. [PSA kinetics after total prostatectomy].
Riedinger JM; Eche N; Fulla Y; Thuillier F
Ann Biol Clin (Paris); 2009; 67(1):39-46. PubMed ID: 19189884
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
